title: Involvement of P2-purinergic receptors in intracellular Ca2+ responses and the contraction of mammary myoepithelial cells.
abstract: Mammary myoepithelial cells were isolated and cultured to characterize their properties. The intracellular calcium concentration (Cai2+) was measured using the ratio of fura-2 fluorescence at 340 nm to that at 360 nm (F340/F360), and the contraction was simultaneously monitored by the change of fluorescence intensity at 360 nm (F360). Cultured myoepithelial cells retained their contractile machinery as in the intact tissue. NBD-phallacidin fluorescence, which marks F-actin, and electron microscopy showed abundant bundles of microfilaments in the cytoplasm. Oxytocin (> 0.1 nM) induced an increase in Cai2+ and contraction. The amplitude and time course of the Cai2+ increase were not markedly affected in the Ca2+-free solution. Nifedipine (10 microM) did not affect the response to oxytocin. ATP (>1 microM) induced an increase in Cai2+ and contraction. The response to ATP was not affected by Ca2+ removal, but was suppressed by suramin (100 microM), an antagonist of P2-purinergic receptors. The order of potency of nucleotides to increase Cai2+ was ATP = ADP > UTP > UDP. These findings indicate the presence of P2-purinergic receptors in mammary myoepithelial cells. The results suggest that stimulant-induced Cai2+ increases and contractions are due to release of Ca2+ from intracellular stores in these cells. In addition to the hormonal action of oxytocin, extracellular nucleotides may function as paracrine agents to contract myoepithelial cells in the mammary gland.
authors.affiliation: Department of Physiological Sciences, The Graduate University for Advanced Studies, National Institute for Physiological Sciences, Okazaki, 444, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Nakano
authors.forename: K
authors.initials: K
authors.lastname: Furuya
authors.forename: S
authors.initials: S
authors.lastname: Furuya
authors.forename: S
authors.initials: S
authors.lastname: Yamagishi
mesh_terms: D000199:Actins / Q000032:analysis; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D005260:Female; D005456:Fluorescent Dyes; D016257:Fura-2; D008321:Mammary Glands, Animal / Q000166:cytology* / Q000187:drug effects; D051379:Mice; D008813:Mice, Inbred ICR; D008854:Microscopy, Electron; D009119:Muscle Contraction; D009543:Nifedipine / Q000494:pharmacology; D009711:Nucleotides / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D018048:Receptors, Purinergic P2 / Q000502:physiology*
chemical_list: D000199:Actins; D002121:Calcium Channel Blockers; D005456:Fluorescent Dyes; D009711:Nucleotides; D018048:Receptors, Purinergic P2; D010121:Oxytocin; D000255:Adenosine Triphosphate; D009543:Nifedipine; D002118:Calcium; D016257:Fura-2